Publication | Closed Access

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Antimicrobial SusceptibilityHealth SciencesAntibioticsVitro SynergismBetter Clinical OutcomesAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceCarbapenem-resistant Gram-negative InfectionsDrug Resistance